High PABPC1 expression was also found in diffuse large B-cell lymphoma (DLBC), head and neck squamous cell carcinoma (HNSC), lung squamous carcinoma (LUSC), prostate cancer (PRAD), and uterine sarcoma (UCS), suggesting that the progression of the above tumors requires high PABPC1 expression (Figure 2). This evidence concerns the gene PABPC1 and uterine corpus sarcoma.